Starting in January 2026, the NHS in England will provide the chickenpox vaccine to children as part of their routine […]

A major study by Eli Lilly has found that patients with early-stage breast cancer who took Verzenio along with standard

Novo Nordisk, the company behind popular weight loss and diabetes drugs Ozempic and Wegovy, is teaming up with Replicate Bioscience

Stay informed about the latest in drug development with BioPharma Dive’s free newsletter, delivered straight to your inbox. In the

Xoma Royalty Corp. has agreed to buy Mural Oncology, a biotech company focused on cancer treatments, for $2.035 per share.

The obesity drug market is currently dominated by two major players: Eli Lilly and Novo Nordisk. Both companies are working

Over the next five years, many top-selling cancer drugs from major pharmaceutical companies will lose their patent protection. This is

A report from the Make America Healthy Again (MAHA) Commission was delayed earlier this month, but leaked documents reveal plans

Measuring how long a cancer treatment extends life (overall survival, or OS) is the best way to judge its effectiveness.

The US Food and Drug Administration (FDA) has given special recognition to a new experimental drug called izalontamab brengitecan (iza-bren).